Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neuroadrenergic Dysfunction Along the Diabetes Continuum: Benefits of Weight Loss Within Different Strata of Metabolic Risk

NCT01771042 is registered in ClinicalTrials.gov with Baker Heart Research Institute as lead sponsor.

NCT NCT01771042
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01771042 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neuroadrenergic Dysfunction Along the Diabetes Continuum: Benefits of Weight Loss Within Different Strata of Metabolic Risk
Lead sponsor
Baker Heart Research Institute
Phase
Not applicable
Overall status
Unknown status
Start date
April 30, 2013
Completion date
April 30, 2017
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic syndrome, obesity, type 2 diabetes